Walgreens Boots Alliance (NASDAQ:WBA) Price Target Cut to $12.00 by Analysts at Truist Financial

Walgreens Boots Alliance (NASDAQ:WBA) had its target price reduced by Truist Financial from $13.00 to $12.00 in a research note published on Friday morning,Benzinga reports. They currently have a hold rating on the pharmacy operator’s stock.

Other analysts also recently issued research reports about the company. Barclays lifted their target price on Walgreens Boots Alliance from $7.00 to $8.00 and gave the company an “underweight” rating in a research note on Wednesday, October 16th. Jefferies Financial Group reduced their price target on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating on the stock in a report on Wednesday, October 23rd. UBS Group increased their price objective on shares of Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a report on Thursday, October 17th. Morgan Stanley reduced their target price on Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating on the stock in a report on Friday, October 11th. Finally, Royal Bank of Canada increased their price target on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a research note on Wednesday, January 15th. Four investment analysts have rated the stock with a sell rating, nine have issued a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $13.19.

Walgreens Boots Alliance Price Performance

NASDAQ WBA opened at $10.28 on Friday. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68. Walgreens Boots Alliance has a 12 month low of $8.08 and a 12 month high of $23.76. The stock has a market cap of $8.88 billion, a price-to-earnings ratio of -1.00, a PEG ratio of 1.41 and a beta of 0.64. The company’s 50 day moving average is $10.09 and its two-hundred day moving average is $9.88.

Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, beating analysts’ consensus estimates of $0.38 by $0.13. The company had revenue of $39.50 billion for the quarter, compared to analysts’ expectations of $37.40 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. Walgreens Boots Alliance’s revenue for the quarter was up 7.6% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.66 EPS. As a group, research analysts anticipate that Walgreens Boots Alliance will post 1.6 earnings per share for the current year.

Institutional Trading of Walgreens Boots Alliance

Hedge funds have recently modified their holdings of the company. First Financial Corp IN grew its stake in Walgreens Boots Alliance by 49.2% during the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock worth $25,000 after buying an additional 885 shares during the last quarter. Golden State Wealth Management LLC purchased a new stake in shares of Walgreens Boots Alliance during the fourth quarter worth about $26,000. Venturi Wealth Management LLC acquired a new position in shares of Walgreens Boots Alliance during the fourth quarter valued at about $28,000. TD Private Client Wealth LLC raised its position in shares of Walgreens Boots Alliance by 8,670.3% in the 3rd quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator’s stock valued at $29,000 after purchasing an additional 3,208 shares during the last quarter. Finally, Sentry Investment Management LLC acquired a new stake in Walgreens Boots Alliance in the 3rd quarter worth approximately $30,000. 58.59% of the stock is owned by hedge funds and other institutional investors.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.